Eli Lilly & Co. (LLY) Tops Q3 EPS by 7c; Offers FY22 EPS Guidance
Tweet
Share
E-mail
Get Alerts LLY Hot Sheet
Price: $1,107.08 +0.45%
Revenue Growth %: +31.7%
Financial Fact:
Research and development: 1.24B
Today's EPS Names:
CBRS, MAYS, CRMT, More
Revenue Growth %: +31.7%
Financial Fact:
Research and development: 1.24B
Today's EPS Names:
CBRS, MAYS, CRMT, More
Join SI Premium – FREE
Eli Lilly & Co. (NYSE: LLY) reported Q3 EPS of $1.98, $0.07 better than the analyst estimate of $1.91. Revenue for the quarter came in at $6.94 billion versus the consensus estimate of $6.91 billion.
GUIDANCE:
Eli Lilly & Co. sees FY2022 EPS of $7.70-$7.85, versus the consensus of $7.99.
For earnings history and earnings-related data on Eli Lilly & Co. (LLY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Lilly declares third-quarter 2026 dividend
- Sangamo files Chapter 11, agrees to sell assets to Lilly, Astellas
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
